Related Experiment Video
Updated: Jul 24, 2025

16:41
A Protocol for Computer-Based Protein Structure and Function Prediction
Published on: November 3, 2011
68.8K
New insights into the pathogenicity of TMEM165 variants using structural modeling based on AlphaFold 2 predictions
Dominique Legrand1, Mélissandre Herbaut1, Zoé Durin1
1Univ. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
Computational and Structural Biotechnology Journal
|July 7, 2023
Summary
TMEM165 mutations cause Congenital Disorders of Glycosylation by disrupting manganese transport. A new 3D model explains how these mutations, even distant ones, affect protein function and Mn2+ transport crucial for glycosylation.
Area of Science:
- Biochemistry
- Structural Biology
- Genetics
Background:
- TMEM165 is a Golgi protein essential for manganese (Mn2+) transport, vital for glycosylation enzymes.
- Mutations in TMEM165 lead to Congenital Disorders of Glycosylation (CDG), impacting patient health.
- Previous topology predictions failed to clarify TMEM165 structure and mutation effects.
Purpose of the Study:
- To elucidate the 3D structure of TMEM165 using advanced modeling techniques.
- To understand how patient-derived and experimental mutations affect TMEM165 function.
- To provide a structural basis for Mn2+ transport and its role in glycosylation.
Main Methods:
- Utilized AlphaFold 2 for initial TMEM165 model construction.
- Refined the model using molecular dynamics simulations with lipids and water.
- Analyzed the structural impact of conserved motifs and specific mutations, like G>R304.
Main Results:
- Developed a refined 3D model of TMEM165 revealing a two-fold repeat structure.
- Identified a putative Mn2+ binding site formed by conserved motifs on the cytosolic side.
- Explained the functional impact of the G>R304 mutation and other mutations on TMEM165 transport.
Conclusions:
- The 3D TMEM165 model offers insights into Mn2+ transport mechanisms and CDG pathogenesis.
- Structural understanding aids in explaining mutation effects on TMEM165 function.
- The model provides a basis for comparing TMEM165 with related transporters in the CaCA2/UPF0016 family and LysE superfamily.
Related Concept Videos
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Structural Protein Function
2.8K
2.8K
Protein Folding
118.5K
Overview
118.5K
Tail-anchoring of Proteins in the ER Membrane
3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K

